A Model for Evaluating and Listing Heart Failure Patients who use Cannabis for Heart Transplantation
O
Onyedika Ilonze
Primary Investigator
Administratively Closed
18 years - 75 years
All
Phase
N/A
2 Locations
Brief description of study
This study is a non-randomized prospective study in which we will assess cannabis-using HF patients referred to an advanced HF center. We will determine the prevalence and patterns of cannabis use in HF patients using the Cannabis Use Disorder Identification Test- Revised (CUDIT-R) and evaluate compliance with medications and treatment regimen using the Morisky medication adherence scale-8 including appointment among patients with HF referred to an advanced HF center. We will then compare this group to a similarly matched non-cannabis using HF cohort.
This study is recruiting patients from the Eskenazi Adult Congenital Heart Disease Program ONLY.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: heart failure, cannabis ,substance use
-
Age: 18 years - 75 years
-
Gender: All
Patients will be included if they meet the following parameters: 1. History of heart failure and either self-reported concurrent present or prior cannabis use within the past 12 months and/or positive urine drug screen for cannabis while either referred to or being managed at an advanced HF center regardless of ejection fraction
Patients will be excluded if they meet the following parameters: 1. Age<18 years old or age>75 years old
Updated on
01 Aug 2024.
Study ID: 13556, KIC-IIR-ILONZE-CANNABIS
